Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed May 17, 2021 · 10-Q · 47 days after period end · 0001437749-21-012409
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$949.30K | -$155.77K | $338.43K | -$13.34K |
| EPS Diluted | -$0.10 | -$0.09 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 17, 2021 · 47 d after period end
